Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

GRML vs PROK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PROK Wins Head-to-Head Institutional Verdict (4–0 across 6 Pillars · 6–2 Matrix Metrics)

PROK Overall Winner 6-Pillar Tally: GRML 0 – 4 PROK (2 Tie) Matrix Metrics: GRML 2 – 6 PROK

As of Nov 16, 2026, ProKidney Corp. Class A (PROK) is the stronger overall head-to-head candidate over GRML (GRML) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GRML carries a Unified Composite Score of 56.8/100 (HOLD) at $3.51 (N/M Forward P/E, N/A operating margin), whereas PROK carries 54.0/100 (HOLD) at $1.03 (N/M Forward P/E, -24830.3% operating margin).

  • Composite vs. Pillar Nuance: While GRML currently prints a higher short-term Unified Composite Score (56.8/100 HOLD vs. PROK 54.0/100 HOLD), PROK captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-24830.3% vs. N/A operating margin) and revenue trajectory (-19.8% vs. N/A YoY).
  • Technical & Structure Timing Caution: GRML trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 37.5); meanwhile PROK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GRML vs PROK
GRML US Equity
GRML
Institutional Equity
$3.51
-2.77% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -5.32β · 95% Vol
Unified Composite Score
56.8 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 37
RSI-14: 37.5 · SMA20: $4.67 · SMA50: $6.11
PROK NASDAQ Head-to-Head Winner
ProKidney Corp. Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.03
-0.96% 1D
Market Cap $415.2M
TTM Revenue $775,000
Forward P/E N/M
Beta / 30D Vol 1.70β · 92% Vol
Unified Composite Score
54.0 / 100 HOLD
Tech 33.0 Fund 65.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.7%), weak momentum, RSI 33
RSI-14: 32.5 · SMA20: $1.25 · SMA50: $1.51

6-Pillar Scorecard Institutional Category Breakdown (GRML 0 – 4 PROK)

Columns: Metric · GRML · PROK
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale PROK
Revenue Growth (YoY) N/A -19.8%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $775,000
Market Cap N/A $415.2M
3. Profitability & Quality PROK
Gross Margin N/A 100.0%
Operating Margin N/A -24830.3%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -73.4%
4. Balance Sheet & Cash Flow PROK
Cash Generation (TTM) N/A -$160M
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $71M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning PROK
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 364.9% (42nd %ile)
Put/Call OI Skew N/A 0.83x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GRML (2) vs PROK (6)
Institutional Metric GRML PROK Criterion Row Edge
Market Capitalization
Scale
N/A $415.2M Larger Scale PROK
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A -19.8% Higher Growth PROK
Operating Margin (TTM)
Profitability
N/A -24830.3% Higher Margin PROK
Net Profit Margin
Profitability
N/A 0.0% Higher Margin PROK
Return on Equity (ROE)
Capital Efficiency
N/A -73.4% Higher ROE PROK
52-Week Range Position
Momentum
19% ($0–$18) 9% ($1–$3) Stronger Trend GRML
Beta / 30D Volatility
Risk Regime
-5.32β · 95% Vol 1.70β · 92% Vol Lower Realized Risk PROK
Unified Institutional Score
Composite Signal
56.8 / 100 (HOLD) 54.0 / 100 (HOLD) Higher Composite GRML
Trailing 12M Revenue (USD)
Operating Scale
N/A $775,000 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$160M ($71M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PROK +19.32 pp
GRML: -41.5% · PROK: -22.18%
3M Horizon GRML +1792.02 pp
GRML: +1767.02% · PROK: -25.0%
6M Horizon GRML +929.76 pp
GRML: +894.05% · PROK: -35.71%
1Y Horizon GRML +703.79 pp
GRML: +650.0% · PROK: -53.79%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRML vs PROK. Trailing 12-month operating profitability (GRML N/A vs PROK -24830.3%) and valuation multiples (GRML N/M vs PROK N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GRML ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PROK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$775,000
Gross Margin100.0%
Op. Margin-24830.3%
ROE / Fwd P/E-73.4% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GRML UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GRML Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PROK BREAKDOWN
50d in phase · OBV ACCUMULATION
Current IV 364.9%
IV Percentile 42nd %ile
Put/Call OI Skew 0.83x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact PROK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GRML Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PROK Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $415.2M market capitalization and -24830.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ GRML vs PROK Key Questions & Quantitative Answers

As of Nov 16, 2026, ProKidney Corp. Class A (PROK) is the stronger overall head-to-head candidate over GRML (GRML) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GRML carries a Unified Composite Score of 56.8/100 (HOLD) at $3.51 (N/M Forward P/E, N/A operating margin), whereas PROK carries 54.0/100 (HOLD) at $1.03 (N/M Forward P/E, -24830.3% operating margin). Composite vs. Pillar Nuance: While GRML currently prints a higher short-term Unified Composite Score (56.8/100 HOLD vs. PROK 54.0/100 HOLD), PROK captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-24830.3% vs. N/A operating margin) and revenue trajectory (-19.8% vs. N/A YoY). Technical & Structure Timing Caution: GRML trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 37.5); meanwhile PROK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PROK leads the Growth & Scale pillar: GRML posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PROK at -19.8% YoY revenue growth and +0.0% YoY earnings growth on $775,000 TTM revenue (100.0% gross margin, -24830.3% operating margin). On trailing 12-month operating scale, GRML generates N/A in USD-normalized revenue versus $775,000 for PROK. In operating R&D and SG&A reinvestment, GRML deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PROK.

GRML and PROK trade at balanced relative valuation multiples. GRML trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PROK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GRML (N/A ROE) versus PROK (-73.4% ROE) capital efficiency.

In options market volatility and institutional positioning, GRML carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-5.32β · 95% Vol realized risk). By comparison, PROK carries 364.9% implied volatility (42nd %ile, Balanced (25th–60th %ile)), a 0.83x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.70β · 92% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.